Neurocrine Biosciences, Inc. (LON:0K6R)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10,044	10,507	11,039	10,163	9,530	5,967
Market Cap Growth	-18.14%	-4.82%	8.62%	6.65%	59.70%	-9.03%
Enterprise Value	9,263	10,035	10,287	9,518	9,101	5,736
Last Close Price	92.28	105.45	108.92	104.04	98.59	63.33
PE Ratio	28.24	29.55	40.49	51.85	74.32	90.18
PS Ratio	4.73	4.94	5.87	6.86	7.71	7.13
PB Ratio	4.16	4.35	5.34	5.80	6.72	5.88
P/TBV Ratio	4.16	4.35	5.43	5.91	6.90	5.88
P/FCF Ratio	18.05	18.89	24.80	35.80	35.56	34.66
P/OCF Ratio	17.27	18.07	23.21	33.20	33.83	31.50
EV/Sales Ratio	4.42	4.72	5.47	6.43	7.37	6.85
EV/EBITDA Ratio	17.35	20.26	21.11	29.14	41.44	35.51
EV/EBIT Ratio	19.86	21.22	22.09	30.71	44.04	37.38
EV/FCF Ratio	16.65	18.04	23.11	33.53	33.96	33.32
Debt / Equity Ratio	0.13	0.13	0.19	0.19	0.15	0.32
Debt / EBITDA Ratio	0.57	0.57	0.76	0.99	0.94	1.88
Debt / FCF Ratio	0.56	0.56	0.89	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.33	-0.33	-0.22	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.60	-1.60	-0.95	-1.45	-2.74	-1.24
Net Debt / FCF Ratio	-1.42	-1.42	-1.04	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.82	0.82	15.99	16.48	14.85	11.71
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	9.53%	9.53%	10.46%	8.78%	7.01%	6.82%
Return on Invested Capital (ROIC)	18.95%	20.58%	22.51%	22.75%	17.26%	19.95%
Return on Capital Employed (ROCE)	16.40%	16.40%	18.20%	15.20%	13.60%	11.40%
Earnings Yield	3.54%	3.38%	2.47%	1.93%	1.35%	1.11%
FCF Yield	5.54%	5.29%	4.03%	2.79%	2.81%	2.89%
Buyback Yield / Dilution	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.